(Q39017833)

English

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

scientific article published on 17 April 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Gadi Lalazar

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Meir Mizrahi

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ilit Turgeman

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Tomer Adar

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ami Ben Ya'acov

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yehudit Shabat

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Assy Nimer

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Nila Hemed

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lidya Zolotarovya

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yoav Lichtenstein

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Nadya Lisovoder

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sarit Samira

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Itamar Shalit

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ronald Ellis

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yaron Ilan

15

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

17 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

399-407

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

CD3-specific antibodies: a portal to the treatment of autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Inflammation and endoplasmic reticulum stress in obesity and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Normalization of obesity-associated insulin resistance through immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Human regulatory T cells and their role in autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Regulatory T cells and infection: a dangerous necessity

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Regulatory T-cell physiology and application to treat autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Making sense of regulatory T cell suppressive function

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

How do CD4+CD25+ regulatory T cells control autoimmunity?

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Cd4+Cd25+ regulatory T cells and their therapeutic potential

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Type 1 diabetes as a relapsing-remitting disease?

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

Tai chi chuan exercise decreases A1C levels along with increase of regulatory T-cells and decrease of cytotoxic T-cell population in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-015-0160-6

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and function of latency-associated nuclear antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engineered CD3 antibodies for immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Surgical intervention in infective endocarditis: indications and timing].

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-015-0160-6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39017833&oldid=2202465191"